StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$0.84−0.30 (-26.34%)

Close on Nov 19, 2026Market cap $4.35MP/E –Yield –

Regentis Biomaterials gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Regentis Biomaterials

Regentis Biomaterials has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Regentis Biomaterials figures

See a number that looks wrong?